HomeNDC LookupRxCUI directory › RxCUI 199055

Metronidazole 375 MG Oral Capsule — RxCUI 199055

RxNorm drug concept · Semantic clinical drug
RxCUI 199055 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 12 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI199055
Official nameMetronidazole 375 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped12
Reported Medicaid activity (SDUD)822 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Metronidazole Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Metronidazole Injection is used when the infection is serious enough that your body needs the medication delivered directly into your bloodstream right away, or when you can't take...
  • Why am I getting this antibiotic through an IV instead of a pill?
  • No — this is really important. Drinking alcohol or consuming anything with propylene glycol (found in some medications and food products) while on metronidazole — or within at leas...
  • Can I drink alcohol while I'm being treated with this?
📖 Read our full Metronidazole Injection guide →

🕸️ Concept Web — How Metronidazole 375 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Metronidazole 375 MG Oral Capsule RxCUI 199055

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Metronidazole 6922
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Flagyl 202866
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Metronidazole Oral Capsule 372895
    • Metronidazole Oral Product 1164083
    • Metronidazole Pill 1164084
    • Metronidazole Oral Capsule [Flagyl] 687210
    • Flagyl Oral Product 1169007
    • Flagyl Pill 1169008
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Metronidazole 375 MG SCDC · 316301
  • Metronidazole Oral Capsule SCDF · 372895
  • Metronidazole Oral Product SCDG · 1164083
  • Metronidazole Pill SCDG · 1164084

Brand-Name Concepts

  • Metronidazole 375 MG Oral Capsule [Flagyl] SBD · 687211
  • Metronidazole 375 MG [Flagyl] SBDC · 687209
  • Metronidazole Oral Capsule [Flagyl] SBDF · 687210
  • Flagyl Oral Product SBDG · 1169007
  • Flagyl Pill SBDG · 1169008
  • Flagyl BN · 202866

📦 FDA Products & Package NDCs

4 products · 12 package NDCs
12 package NDCs map to RxCUI 199055 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00025-1942-34 100 BLISTER PACK in 1 CARTON (0025-1942-34) / 1 CAPSULE in... Flagyl Pfizer Laboratories Div Pfizer Inc 1995-05-03
46708-0435-30 30 CAPSULE in 1 BOTTLE (46708-435-30) Metronidazole Alembic Pharmaceuticals Limited 2016-12-09
46708-0435-31 100 CAPSULE in 1 BOTTLE (46708-435-31) Metronidazole Alembic Pharmaceuticals Limited 2016-12-09
46708-0435-50 50 CAPSULE in 1 BOTTLE (46708-435-50) Metronidazole Alembic Pharmaceuticals Limited 2016-12-09
46708-0435-71 500 CAPSULE in 1 BOTTLE (46708-435-71) Metronidazole Alembic Pharmaceuticals Limited 2016-12-09
46708-0435-91 1000 CAPSULE in 1 BOTTLE (46708-435-91) Metronidazole Alembic Pharmaceuticals Limited 2016-12-09
62135-0836-50 50 CAPSULE in 1 BOTTLE (62135-836-50) Metronidazole Chartwell RX, LLC 2024-02-15
62332-0018-30 30 CAPSULE in 1 BOTTLE (62332-018-30) Metronidazole Alembic Pharmaceuticals Inc. 2016-12-09
62332-0018-31 100 CAPSULE in 1 BOTTLE (62332-018-31) Metronidazole Alembic Pharmaceuticals Inc. 2016-12-09
62332-0018-50 50 CAPSULE in 1 BOTTLE (62332-018-50) Metronidazole Alembic Pharmaceuticals Inc. 2016-12-09
62332-0018-71 500 CAPSULE in 1 BOTTLE (62332-018-71) Metronidazole Alembic Pharmaceuticals Inc. 2016-12-09
62332-0018-91 1000 CAPSULE in 1 BOTTLE (62332-018-91) Metronidazole Alembic Pharmaceuticals Inc. 2016-12-09
Observed labelers: Alembic Pharmaceuticals Inc. (5) · Alembic Pharmaceuticals Limited (5) · Chartwell RX, LLC (1) · Pfizer Laboratories Div Pfizer Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$7.3080
Range $7.3080–$7.3080 · middle 50% $7.3080–$7.3080 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.